Pfizer CEO Says Waiving Vaccine IP Rights Out of the Question

Pfizer CEO Albert Bourla decried on Sunday the idea of waiving Pfizer’s intellectual property rights in order to speed up vaccine distribution to poorer countries.”I think the intellectual property is what created the thriving life sciences sector that was ready when the…

Related articles

You may also be interested in

Headline

Never Miss A Story

Get our Weekly recap with the latest news, articles and resources.
Cookie policy

We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.